Imanis Life Sciences specializes in providing custom virus and cell solutions to support the development of advanced therapeutic modalities, including oncolytic virus therapies, gene and cell therapies, regenerative medicines, and vaccines. Their offerings include the generation of custom cell lines, lentiviral vectors, and adeno-associated viruses (AAVs), all tailored to meet specific research needs. Imanis employs a rigorous quality control process to ensure that all custom products, developed by experienced scientists, maintain high standards of reliability and efficacy. Their lentiviral vectors are designed for efficient transduction across various cell types, while their AAV vectors can be customized based on specific serotypes and genes of interest.

In addition to custom products, Imanis Life Sciences provides comprehensive assay development and validation services. Their expertise encompasses a wide range of bioanalytical tests, including molecular-based biodistribution assays, pharmacokinetic and immunogenicity testing, and cell-based neutralizing antibody assays. Utilizing advanced instrumentation and validated systems, Imanis supports drug development from discovery through clinical phases, ensuring compliance with regulatory standards. Their capabilities also extend to multiplex cytokine profiling and flow cytometric analyses, enabling detailed immunological assessments that are crucial for evaluating the safety and efficacy of biopharmaceutical products.

United States

Imanis Life Sciences has an unwavering commitment to the advancement of science. For many companies, profitability rules decision making. But at Imanis, leading scientific breakthroughs is the primary focus. We are about making a difference in the world by putting people in a better position than they were yesterday. We strive to do this by being a leader in laboratory assays and research services to accelerate the development of a broad range of next-generation therapies.

Imanis Life Sciences

Company Details